Invesco Ltd. - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 112 filers reported holding THERAVANCE INC in Q1 2015. The put-call ratio across all filers is 57.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$13,233,000
+86.0%
1,255,547
+26.7%
0.01%
+66.7%
Q3 2015$7,115,000
+142200.0%
990,930
+357636.5%
0.00%
Q2 2015$5,000
-100.0%
277
-100.0%
0.00%
-100.0%
Q1 2015$12,563,000
+24.9%
799,177
+145.9%
0.01%
+25.0%
Q1 2014$10,056,000
+1235.5%
325,013
+1438.9%
0.00%
Q4 2013$753,000
+4.0%
21,120
+19.3%
0.00%
Q3 2013$724,000
+9.4%
17,710
+3.1%
0.00%
Q2 2013$662,00017,1800.00%
Other shareholders
THERAVANCE INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baupost Group 20,144,301$718,144,00020.35%
Litespeed Management, L.L.C. 1,636,994$58,359,0008.44%
Realm Partners LLC 240,794$8,585,0007.27%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,828,059$100,820,0004.97%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,456,503$265,824,0003.15%
SECTORAL ASSET MANAGEMENT INC 1,973,188$70,344,0003.03%
Foundation Asset Management, LP 221,796$7,907,0002.06%
Rhenman & Partners Asset Management AB 132,000$4,706,0001.84%
BB BIOTECH AG 888,244$31,666,0001.69%
HealthCor Management, L.P. 725,000$25,846,0001.57%
View complete list of THERAVANCE INC shareholders